{"text": ["AbbVie", "Inflated", "Prices", "For", "Two", "Major", "Drugs,", "Engaged", "In", "Anticompetitive", "Practices,", "House", "Oversight", "Report", "Says"], "created_at": "2021-05-18 21:47:21"}
{"text": ["House", "Committee", "Takes", "On", "Pricing,", "Patents", "for", "Top-Selling", "Drug", "Humira"], "created_at": "2021-05-18 19:40:00"}
{"text": ["U.S.", "lawmakers", "request", "federal", "inquiry", "into", "AbbVie's", "actions", "with", "drug", "Humira", "-statement"], "created_at": "2021-05-18 15:30:53"}
{"text": ["AbbVie", "Slammed", "in", "House", "Report", "for", "Pricing", "Practices.", "Market", "Shrugs."], "created_at": "2021-05-18 15:17:00"}
{"text": ["UPDATE", "3-Lawmakers", "say", "AbbVie", "exploits", "U.S.", "patents", "to", "protect", "Humira", "profits,", "price", "hikes"], "created_at": "2021-05-18 13:48:15"}
{"text": ["After", "a", "Blowout", "Quarter,", "Is", "AbbVie", "Stock", "a", "Buy?"], "created_at": "2021-05-18 13:28:10"}
{"text": ["AbbVie", "exploits", "U.S.", "patents", "to", "protect", "profits:", "Congress", "report"], "created_at": "2021-05-18 13:00:00"}
